
Early COVID-19 Vaccine Patent In China Raises New Questions For U.S. Investigators
A Chinese patent for a COVID-19 vaccine filed just weeks after the virus emerged in the United States is drawing fresh scrutiny from U.S. investigators examining the origins of the pandemic…[...]
Read More